Recent advances in TGFβ-regulated transcription during carcinogenesis

Signal Transduction

Volumn 6, Issue 5, 2006, Pages 345-354

  Buck, Anita ^a   Ellenrieder, Volker ^b  

^a UNIVERSITY OF ULM   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Carcinogenesis; TGF

Indexed keywords

SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

CANCER GROWTH; CARCINOGENESIS; CYTOPLASM; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; GENE REPRESSION; HUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 33750056393     PISSN: 16154053     EISSN: 16154061     Source Type: Journal    
DOI: 10.1002/sita.200600093     Document Type: Review

References (88)

1. Massague, J. (2004) G1 cell-cycle control and cancer. Nature 432: 298-306.
2. Ten Dijke, P., Goumans, M. J., Itoh, F., Itoh, S. (2002) Regulation of cell proliferation by Smad proteins. J. Cell Physiol. 191: 1-16.
3. Seoane, J. (2006) Escaping from the TGF{beta} anti-proliferative control. Carcinogenesis, DOI 10.1093/carecin/bg1068.
4. Massague, J., Seoane, J., Wotton, D. (2005) Smad transcription factors. Genes Dev. 19: 2783-2810.
5. Keski-Oja, J., Koli, K., von Melchner, H. (2004) TGF-beta activation by traction? Trends Cell Biol. 14: 657-659.
6. Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J., et al. (1999) The integrin alpha v beta 6 binds and activates latent TGFbeta 1: a mechanism for regulation pulmonary inflammation and fibrosis. Cell 5: 319-328
7. ten Dijke, P., Hill, C. S. (2004) New insights into TGF-beta-Smad signalling. Trends Biochem. Sci. 29: 265-273.
8. Krishnaveni, M. S., Eickelberg, O. (2006) Signal Transduction 6: 301-313.
9. Hart, P. J., Deep, S., Taylor, A. B., Shu, Z., et al. (2002) Crystal structure of the human TGFbetaR2 ectodomain-TGF-beta3 complex. Nat. Struct. Biol. 9: 203-208.
10. Kang, Y., He, W., Tulley, S., Gupta, G. P., et al. (2005) Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl. Acad. Sci. U. S. A. 102: 13909-13914.
11. Moustakas, A., Heldin, C. H. (2005) Non-Smad TGF-beta signals. J. Cell Sci. 118: 3573-3584.
12. Miyazono, K., ten Dijke, P., Heldin, C. H. (2000) TGF-beta signaling by Smad proteins. Adv. Immunol. 75: 115-157.
13. Tsukazaki, T., Chiang, T. A., Davison, A. F., Attisano, L., Wrana, J. L. (1998) SARA, a FYVE domain protein that recruits Smad2 to the TGFbeta receptor. Cell 95: 779-791.
14. Inman, G. J., Hill, C. S. (2002) Stoichiometry of active smad-transcription factor complexes on DNA. J. Biol. Chem. 277: 51008-51016.
15. He, W., Dorn, D. C., Erdjument-Bromage, H., Tempst, P., et al. (2006) Hematopoiesis controlled by distinct TIF1-gamma and Smad4 branches of the TGFbeta pathway. Cell 125: 929-941.
16. Nakao, A., Afrakhte, M., Moren, A., Nakayama, T., et al. (1997) Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389: 631-635.
17. Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., et al. (1997) The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89: 1165-1173.
18. Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., et al. (2000) Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell 6: 1365-1375.
19. Suzuki, C., Murakami, G., Fukuchi, M., Shimanuki, T., et al. (2002) Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane. J. Biol. Chem. 277: 39919-39925.
20. Tajima, Y., Goto, K., Yoshida, M., Shinomiya, K., et al. (2003) Chromosomal region maintenance 1 (CRM1)-dependent nuclear export of Smad ubiquitin regulatory factor 1 (Smurf1) is essential for negative regulation of transforming growth factor-beta signaling by Smad7. J. Biol. Chem. 278: 10716-10721.
21. Breitkopf, K., Weng, H., Dooley, S. (2006) Signal Transduction 6: 329-337.
22. Dupont, S., Zacchigna, L., Cordenonsi, M., Soligo, S., et al. (2005) Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 121: 87-99.
23. Vincent, F., Nagashima, M., Takenoshita, S., Khan, M. A., et al. (1997) Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta. Oncogene 15: 117-122.
24. Markowitz, S., Wang, J., Myeroff, L., Parsons, R., et al. (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336-1338.
25. Myeroff, L. L., Parsons, R., Kim, S. J., Hedrick, L., et al. (1995) A transforming growth factor beta receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res. 55: 5545-5547.
26. Knaus, P. I., Lindemann, D., DeCoteau, J. F., Perlman, R., et al. (1996) A dominant inhibitory mutant of the type II transforming growth factor beta receptor in the malignant progression of a cutaneous T-cell lymphoma. Mol. Cell. Biol. 16: 3480-3489.
27. Taipale, J., Saharinen, J., Keski-Oja, J. (1998) Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. Adv. Cancer Res. 75: 87-134.
28. Villanueva, A., Garcia, C., Paules, A. B., Vicente, M., et al. (1998) Disruption of the antiproliferative TGF-beta signaling pathways in human pancreatic cancer cells. Oncogenel 17: 1969-1978.
29. Grady, W. M., Myeroff, L. L., Swinler, S. E., Rajput, A., et al. (1999) Mutational inactivation of transforming growth factor beta receptor type II in microsatellite stable colon cancers. Cancer Res. 59: 320-324.
30. Hahn, S. A., Schutte, M., Hoque, A. T., Moskaluk, C. A., et al. (1996) DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350-353.
31. Merg, A., Howe, J. R. (2004) Genetic conditions associated with intestinal juvenile polyps. Am. J. Med. Genet. C Semin. Med. Genet. 129: 44-55.
32. Massague, J., Chen, Y. G. (2000) Controlling TGF-beta signaling. Genes Dev. 14: 627-644.
33. Hocevar, B. A., Smine, A., Xu, X. X., Howe, P. H. (2001) The adaptor molecule Disabled-2 links the transforming growth factor beta receptors to the Smad pathway. EMBO J. 20: 2789-2801.
34. Yamakawa, N., Tsuchida, K., Sugino, H. (2002) The ras-GAP-binding protein, Dok-1, mediates activin signaling via serine/threonine kinase receptors. EMBOJ. 21: 1684-1694.
35. Tang, Y., Katuri, V., Dillner, A., Mishra, B., et al. (2003) Disruption of transforming growth factor-beta signaling in ELF beta-spectrin-deficient mice. Science 299: 574-577.
36. Lin, H. K., Bergmann, S., Pandolfi, P. P. (2004) Cytoplasmic PML function in TGF-beta signalling. Nature 431: 205-211.
37. Wurthner, J. U., Frank, D. B., Felici, A., Green, H. M., et al. (2001) Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone. J. Biol. Chem. 276: 19495-19502.
38. Felici, A., Wurthner, J. U., Parks, W. T., Giam, L. R., et al. (2003) TLP, a novel modulator of TGF-beta signaling, has opposite effects on Smad2- and Smad3-dependent signaling. EMBO J. 22: 4455-4477.
39. Ellenrieder, V., Buck, A., Gress, T. M. (2002) TGFbeta-regulated transcriptional mechanisms in cancer. Int. J. Gastrointest. Cancer 31: 61-69.
40. Almoguera, C., Shibata, D., Forrester, K., Martin, J., et al. (1988) Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 53: 549-554.
41. Kalthoff, H., Schmiegel, W., Roeder, C., Rasche, D., et al. (1993) p53 and K-RAS alterations in pancreatic epithelial cell lesions. Oncogene 8: 289-298.
42. Kretzschmar, M., Doody, J., Timokhina, I., Massague, J. (1999) A mechanism of repression of TGFbeta/Smad signaling by oncogenic Ras. Genes Dev. 13: 804-816.
43. Moustakas, A., Souchelnytskyi, S., Heldin, C. H. (2001) Smad regulation in TGF-beta signal transduction. J. Cell Sci. 114: 4359-4369.
44. Wrana, J. L. (2000) Regulation of Smad activity. Cell 100: 189-192.
45. Berg, F., Delvoux, B., Gao, C., Westhoff, J. H., et al. (2002) Divergence of TGFbeta signaling in activated hepatic stellate cells downstream from Smad2 phosphorylation. Signal Transduction 2: 11-28.
46. Yue, J., Mulder, K. M. (2000) Activation of the mitogen-activated protein kinase pathway by transforming growth factor-beta. Methods Mol. Biol. 142: 125-131.
47. Lehmann, K., Janda, E., Pierreux, C. E., Rytomaa, M., et al. (2000) Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: a mechanism leading to increased malignancy in epithelial cells. Genes Dev. 14: 2610-2622.
48. de Borst, M. H., Wassef, L., Kelly, D. J., van Goor, H., Navis, G. (2006) Mitogen activated protein kinase signaling in the kidney: target for intervention? Signal Transduction 6: 32-53.
49. Derynck, R., Zhang, Y. E. (2003) Smad-dependent and Smad-independent pathways in TGF-beta family signaling. Nature 425: 577-584.
50. Ellenrieder, V., Hendler, S. F., Boeck, W., Seufferlein, T., et al. (2001) Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res. 61: 4222-4228.
51. Ungefroren, H., Lenschow, W., Chen, W. B., Faendrich, F., Kalthoff, H. (2003) Regulation of biglycan gene expression by transforming growth factor-beta requires MKK6-p38 mitogen-activated protein Kinase signaling downstream of Smad signaling. J. Biol. Chem. 278: 11041-11049.
52. Ungefroren, H., Groth, S., Ruhnke, M., Kalthoff, H., Fandrich, F. (2005) Transforming growth factor-beta (TGF-beta) type I receptor/ALK5-dependent activation of the GADD45beta gene mediates the induction of biglycan expression by TGF-beta. J. Biol. Chem. 280: 2644-2652.
53. Wang, T., Li, B. Y., Danielson, P. D., Shah, P. C., Rockwell, S., et al. (1996) The immunophilin FKBP12 functions as a common inhibitor of the TGF beta family type I receptors. Cell 86: 435-444.
54. Griswold-Prenner, I., Kamibayashi, C., Maruoka, E. M., Mumby, M. C., Derynck, R. (1998) Physical and functional interactions between type I transforming growth factor beta receptors and Balpha, a WD-40 repeat subunit of phosphatase 2A. Mol. Cell. Biol. 18: 6595-6604.
55. Petritsch, C., Beug, H., Balmain, A., Oft, M. (2000) TGF-beta inhibits p70 S6 kinase via protein phosphatase 2A to induce G(1) arrest. Genes Dev. 14: 3093-3101.
56. Giehl, K., Menke, A. (2006) Moving on: Molecular mechanisms in TGFβ-induced epithelial cells migration. Signal Transduction 6: 355-364.
57. Bhowmick, N. A., Ghiassi, M., Bakin, A., Aakre, M., et al. (2001) Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Mol. Biol. Cell 12: 27-36.
58. Miyazaki, M., Sakaguchi, M., Akiyama, I., Sakaguchi, Y., et al. (2004) Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells. Cancer Res. 64: 4155-4161.
59. Sakaguchi, M., Miyazaki, M., Sonegawa, H., Kashiwagi, M., et al. (2004) PKCalpha mediates TGFbeta-induced growth inhibition of human keratinocytes via phosphorylation of S100C/A11. J. Cell Biol. 164: 979-984.
60. Feng, X. H., Lin, X., Derynck, R. (2000) Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15(Ink4B) transcription in response to TGF-beta. EMBO J. 19: 5178-5193.
61. Pardali, K., Kurisaki, A., Moren, A., ten Dijke, P., et al. (2000) Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta. J. Biol. Chem. 275: 29244-29256.
62. Massague, J., Blain, S. W., Lo, R. S. (2000) TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 103: 295-309.
63. Zawel, L., Dai, J. L., Buckhaults, P., Zhou, S., et al. (1998) Human Smad3 and Smad4 are sequence-specific transcription activators. Mol. Cell 1: 611-617.
64. Jungert, K., Buck, A., Buchholz, M., Wagner, M., et al. (2006) Smad-Sp1 complexes mediate TGFβbeta)-induced early transcription of oncogenic Smad7 in pancreatic cancer cells. Carcinogenesis, DOI 10.1093/carcin/bgl078.
65. Chen, X., Rubock, M. J., Whitman, M. (1996) A transcriptional partner for MAD proteins in TGF-beta signalling. Nature 383: 691-696.
66. Seoane, J., Le, H. V., Shen, L., Anderson, S. A., Massague, J. (2004) Integration of Smad and forkhead pathways in the control of neuroepithelial and glioblastoma cell proliferation. Cell 117: 211-223.
67. Hanai, J., Chen, L. F., Kanno, T., Ohtani-Fujita, N., et al. (1999) Interaction and functional cooperation of PEBP2/CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J. Biol. Chem. 274: 31577-31582.
68. Zhang, Y., Derynck, R. (2000) Transcriptional regulation of the transforming growth factor-beta -inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members. J. Biol. Chem. 275: 16979-16985.
69. Pardali, E., Xie, X. Q., Tsapogas, P., Itoh, S., et al. (2000) Smad and AML proteins synergistically confer transforming growth factor beta1 responsiveness to human germ-line IgA genes. J. Biol. Chem. 275: 3552-3560.
70. Alliston, T., Choy, L., Ducy, P., Karsenty, G., Derynck, R. (2001) TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J. 20: 2254-2272.
71. van Dam, H., Castellazzi, M. (2001) Distinct roles of Jun: Fos and Jun: ATF dimers in oncogenesis. Oncogene 20: 2453-2464.
72. Shaulian, E., Karin, M. (2002) AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4: E131-E136.
73. Recio, J. A., Merlino, G. (2002) Hepatocyte growth factor/scatter factor activates proliferation in melanoma cells through p38 MAPK, ATF-2 and cyclin D1. Oncogene 21: 1000-1008.
74. Wong, C., Rougier-Chapman, E. M., Frederick, J. P., Datto, M. B., et al. (1999) Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta. Mol. Cell. Biol. 19: 1821-1830.
75. Zhang, Y., Feng, X. H., Derynck, R. (1998) Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription. Nature 394: 909-913.
76. Hall, M. C., Young, D. A., Waters, J. G., Rowan, A. D., et al. (2003) The comparative role of activator protein 1 and Smad factors in the regulation of Timp-1 and MMP-1 gene expression by transforming growth factor-beta 1. J. Biol. Chem. 278: 10304-10313.
77. Bai, R. Y., Koester, C., Ouyang, T., Hahn, S. A., et al. (2002) SMIF, a Smad4-interacting protein that functions as a coactivator in TGFbeta signalling. Nat. Cell Biol. 4: 181-190.
78. Yahata, T., de Caestecker, M. P., Lechleider, R. J., Andriole, S., et al. (2000) The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors. J. Biol. Chem. 275: 8825-8834.
79. Shimizu, K., Bourillot, P. Y., Nielsen, S. J., Zorn, A. M., Gurdon, J. B. (2001) Swift is a novel BRCT domain coactivator of Smad2 in transforming growth factor beta signaling. Mol. Cell. Biol. 21: 3901-3912.
80. Kato, Y., Habas, R., Katsuyama, Y., Naar, A. M., He, X. (2002) A component of the ARC/Mediator complex required for TGF beta/Modal signalling. Nature 418: 641-646
81. Chen, C. R., Kang, Y., Massague, J. (2001) Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program. Proc. Natl. Acad. Sci. U. S. A. 98: 992-999.
82. Zavadil, J., Bitzer, M., Liang, D., Yang, Y. C., et al. (2001) Genetic programs of epithelial cell plasticity directed by transforming growth factor-beta. Proc. Natl. Acad. Sci. U. S. A. 98: 6686-6691.
83. Kang, Y., Chen, C. R., Massague, J. (2003) A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Mol. Cell 11: 915-926.
84. Siegel, P. M., Massague, J. (2003) Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. Nat. Rev. Cancer 3: 807-821.
85. Chen, C. R., Kang, Y., Siegel, P. M., Massague, J. (2002) E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 110: 19-32.
86. Frederick, J. P., Liberati, N. T., Waddell, D. S., Shi, Y., Wang, X. F. (2004) Transforming growth factor beta-mediated transcriptional repression of c-myc is dependent on direct binding of Smad3 to a novel repressive Smad binding element. Mol. Cell Biol. 24: 2546-2559.
87. Kang, J. S., Alliston, T., Delston, R., Derynck, R. (2005) Repression of Runx2 function by TGF-beta through recruitment of class II histone deacetylases by Smad3. EMBO J. 24: 2543-2555.
88. Vega, R. B., Matsuda, K., Oh, J., Barbosa, A. C., et al. (2004) Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell 119: 555-566.